Werewolf Therapeutics Inc
NASDAQ:HOWL

Watchlist Manager
Werewolf Therapeutics Inc Logo
Werewolf Therapeutics Inc
NASDAQ:HOWL
Watchlist
Price: 2.3 USD 2.68% Market Closed
Market Cap: 100.5m USD
Have any thoughts about
Werewolf Therapeutics Inc?
Write Note

Werewolf Therapeutics Inc
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Werewolf Therapeutics Inc
Stock-Based Compensation Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Werewolf Therapeutics Inc
NASDAQ:HOWL
Stock-Based Compensation
$8m
CAGR 3-Years
133%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Stock-Based Compensation
$872m
CAGR 3-Years
8%
CAGR 5-Years
16%
CAGR 10-Years
14%
Gilead Sciences Inc
NASDAQ:GILD
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Stock-Based Compensation
$685.6m
CAGR 3-Years
18%
CAGR 5-Years
15%
CAGR 10-Years
16%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Werewolf Therapeutics Inc's Stock-Based Compensation?
Stock-Based Compensation
8m USD

Based on the financial report for Dec 31, 2023, Werewolf Therapeutics Inc's Stock-Based Compensation amounts to 8m USD.

What is Werewolf Therapeutics Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 3Y
133%

Over the last year, the Stock-Based Compensation growth was 8%. The average annual Stock-Based Compensation growth rates for Werewolf Therapeutics Inc have been 133% over the past three years .

Back to Top